Loading…
Based on limited metadata without access to the full warning letter text, Unipharma, LLC, a drug manufacturer, received an FDA Warning Letter on November 6, 2019. The specific nature of the violations cannot be determined from the available metadata, as no subject line was provided. The letter was issued under FDA's drug product authority, though the specific issuing office is not identified in the metadata provided.